Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |